Skip to main content

Table 3 Correlation and discrepancies between genotype and phenotype of Campylobacter spp. resistance profile using AMR FinderPlus

From: Identification of knowledge gaps in whole-genome sequence analysis of multi-resistant thermotolerant Campylobacter spp.

Antibiotic class

Antibiotic tested

#Isolates tested

#Isolates resistant

Resistance determinant

Correlation between pheno- and genotype

Reason for discrepancy†

Aminoglycosides

GEN

494

114

aph(2’’)-li1, aph(2’’)-If, bifunctional aac(6’)-Ie/aph(2’’)-Ia

99.1% (113/114)

isolate with yet unknown resistance determinant (MIC > 16 mg/L; GEN-R; n = 1),

STR

494

143

aadE1-3, aadE-Cc, RpsL_K43R, RpsL_K88R

78.1% (114/146)

aadE3 gene not found (missing in database (WP_057035408.1); STR-R; n = 29), partial aadE1 genes (STR-R; n = 2), isolate slightly resistant (MIC = 8 mg/L), but harboring none of the known resistance determinants (n = 1)

KAN

157

139

aph(2’’)-If, bifunctional aac(6’)-Ie/aph(2’’)-Ia, aph(3’)-IIIa

100% (139/139)

n.a.

 

SPC

139

118

aad9

30.5% (36/118)

partial genes found due to frame-shift within poly-C tract (SPC-R; n = 82)

β-Lactams

AMP

139

134

blaOXA−61 and − 184 family genes

98.5% (132/134)

Isolate susceptible (MIC = 16 mg/L), but harboring blaOXA−193 (n = 1); isolate slightly resistant (MIC = 32 mg/L), but harboring no blaOXA gene (n = 1)

(Fluoro-) Quinolones

CIP

494

442

GyrA_T86I, GyrA_T86V

100% (442/442)

n.a.

NAL

494

432

GyrA_T86I, GyrA_T86V

97.7% (432/442)

CIP-R/NAL-S phenotype, yet unknown mechanism (n = 10)

Lincosamides

LCM

44

35

lnu(C), 23S_A2075G, erm(B)

88.6% (31/35)

isolates slightly resistant (MIC = 16 mg/L), but harboring none of the known resistance determinants (n = 4)

Macrolides

ERY

494

115

23S_A2075G, erm(B)

100% (115/115)

n.a.

50S_L22_A103V

20% (31/155)

point mutation not associated with resistance to erythromycin; 20% correlation due to additional presence of either 23_A2075G or erm(B)

Nourseothricin

NTC

98

56**

sat4

100% (56/56)

n.a.

Phenicols

CHL

130

93

catA9, catA13, fexA, optrA

100% (94/94)

n.a.

FLO

53

29

fexA, optrA

62.1% (18/29)

isolates slightly resistant (MIC = 8–16 mg/L) in absence of known phenicol resistance determinants (n = 11)

Tetracyclines

TET

494

412

tet(O), tet(O/32/O), tet(W), tet(O/M/O), tet(L)

84.6% (351*/415)

partial (mosaic-) tet(O) genes found (TET-R; n = 54), (mosaic-) tet(O) genes not found, but phenotypic resistance expressed (under coverage threshold; TET-R; n = 8), tet(W) with two point mutations (G511A/G1736A leading to D171N/G579D; TET-S; n = 2)

  1. AMP, ampicillin; CHL, chloramphenicol; CIP, ciprofloxacin; ERY, erythromycin; FLO, florfenicol; GEN, gentamicin; KAN, kanamycin; LCM, lincomycin; NAL, nalidixic acid; NTC, nourseothricin; SPC, spectinomycin; STR, streptomycin; TET, tetracycline; n.a., not applicable (100% correlation); * tet(O/32/O) found as tet(O) with reduced identity (93.4%; missing in database; TET-R; n = 41) not depicted here, since pheno- and genotype were consistent with only incorrect nomenclature; **Considering a cut-off value of > 4 mg/L as resistant; †Based on the prediction of resistance determinants obtained via the BakCharak pipeline (comprises the AMRFinderPlus tool and its corresponding database version 2023-08-08.2)